NCT06424964View on ClinicalTrials.gov

Use of Long-Acting Injectable Cabotegravir/Rilpivirine for the Treatment of HIV in Belgium

RecruitingOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

January 13, 2025

Primary Completion Date

May 31, 2025

Study Completion Date

July 31, 2025

Conditions

Human Immunodeficiency Virus

Trial Locations (1)

Unknown

RECRUITING

Saint-Pierre University Hospital, Brussels

All Listed Sponsors

lead

Belgian Research on AIDS and HIV Consortium

OTHER